KOA SHOJI HOLDINGS CO.,LTD. Logo

KOA SHOJI HOLDINGS CO.,LTD.

Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.

9273 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
横浜市港北区日吉七丁目13−15
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KOA SHOJI HOLDINGS CO., LTD. is a pharmaceutical holding group operating a dual business model that combines a trading company and a manufacturer. The group specializes in supporting the pharmaceutical industry "from upstream" by importing and distributing high-quality, safe, and reliable Active Pharmaceutical Ingredients (APIs) for the Japanese market. In addition to its core trading activities, the company also manufactures and sells generic drugs. Its integrated operations, which include contract manufacturing and packaging services, aim to provide a stable supply chain for its customers and address the healthcare needs of an aging society.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KOA SHOJI HOLDINGS CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 03:20
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-02-13 05:00
Interim Report
半期報告書-第11期(2024/07/01-2025/06/30)
Japanese 191.9 KB
2025-02-13 05:00
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-30 08:27
Regulatory News Service
臨時報告書
Japanese 24.6 KB
2024-09-30 08:26
Regulatory News Service
内部統制報告書-第10期(2023/07/01-2024/06/30)
Japanese 23.4 KB
2024-09-30 08:26
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-30 08:25
Annual Report
有価証券報告書-第10期(2023/07/01-2024/06/30)
Japanese 1.5 MB
2024-06-26 08:25
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2024-06-05 09:30
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 86.2 KB
2024-06-05 09:30
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 171.1 KB
2024-05-27 08:00
Prospectus
有価証券届出書(参照方式)
Japanese 101.1 KB
2024-05-27 08:00
Prospectus
有価証券届出書(参照方式)
Japanese 250.3 KB
2024-05-13 08:30
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-13 08:30
Quarterly Report
四半期報告書-第10期第3四半期(2024/01/01-2024/03/31)
Japanese 156.7 KB
2024-02-14 07:30
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all KOA SHOJI HOLDINGS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KOA SHOJI HOLDINGS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan 2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary GWPH
Grifols S.A. Logo
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain GRF
Grindeks Logo
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia GRD1R
Guard Therapeutics International AB Logo
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden GUARD
Haleon PLC Logo
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom HLN
Halychpharm Logo
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine GFARM
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A

Talk to a Data Expert

Have a question? We'll get back to you promptly.